Overexpression of miR-19b impairs cardiac development in zebrafish by targeting ctnnb1

Cellular Physiology and Biochemistry

Volumn 33, Issue 6, 2014, Pages 1988-2002

  Li, Mengmeng ^a   Hu, Xiaoshan ^a   Zhu, Jingai ^a   Zhu, Chun ^a   Zhu, Shasha ^a   Liu, Xuehua ^a   Xu, Jing ^a   Han, Shuping ^a   Yu, Zhangbin ^a  

^a WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac development; ctnnb1; miR 19b; Zebrafish

Indexed keywords

CADHERIN ASSOCIATED PROTEIN BETA 1; LITHIUM CHLORIDE; MICRORNA; MICRORNA 19B; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; BETA CATENIN; CTNNB PROTEIN, ZEBRAFISH; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MIRN19 MICRORNA, ZEBRAFISH; ZEBRAFISH PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR CANAL; CARDIOVASCULAR MALFORMATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; HATCHING; HEART CONTRACTION; HEART DEVELOPMENT; HEART EDEMA; HEART FUNCTION; HEART RATE; IN VIVO STUDY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY; ZEBRA FISH; CONGENITAL HEART MALFORMATION; FERTILIZATION; PHENOTYPE; PROTEIN EXPRESSION; ANIMAL; ANIMAL EMBRYO; ANTAGONISTS AND INHIBITORS; CONGENITAL MALFORMATION; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART MUSCLE; IN SITU HYBRIDIZATION; METABOLISM; PATHOLOGY; PERICARDIAL EFFUSION;

DANIO RERIO;

ANIMALS; BETA CATENIN; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOGEN SYNTHASE KINASE 3; HEART; IN SITU HYBRIDIZATION; LITHIUM CHLORIDE; MICRORNAS; MYOCARDIUM; PERICARDIAL EFFUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84904598239     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362975     Document Type: Article

References (41)

1. Dolk H, Loane M, Garne E: Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 2005. Circulation 2011;123:841-849.
2. Ramsdell AF: Left-right asymmetry and congenital cardiac defects: getting to the heart of the matter in vertebrate left-right axis determination. Dev Biol 2005;288:1-20.
3. Harvey RP: Patterning the vertebrate heart. Nat Rev Genet 2002;3:544-556.
4. Chen J, Wang DZ: microRNAs in cardiovascular development. J Mol Cell Cardiol 2012;52:949-957.
5. Chen K, Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93-103.
6. Jackson RJ, Standart N: How do microRNAs regulate gene expression? Sci STKE 2007;367: re1 .
7. Chen J, Huang ZP, Seok HY, Ding J, Kataoka M, Zhang Z, Hu X, Wang G, Lin Z, Wang S, Pu WT, Liao R, Wang DZ: mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 2013;112:1557-1566.
8. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L: miR-19 is a key oncogenic component of mir-17-92. Genes Dev 2009;23:2839-2849.
9. Gittenberger-de Groot AC, Bartelings MM, Deruiter MC, Poelmann RE: Basics of cardiac development for the understanding of congenital heart malformations. Pediatr Res 2005;57:169-176.
10. Kwon C, Cordes KR, Srivastava D: Wnt/beta-catenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis. Cell Cycle 2008;7:3815-3818.
11. Niessen K, Karsan A: Notch signaling in cardiac development. Circ Res 2008;102:1169-1181.
12. Keegan BR, Feldman JL, Begemann G, Ingham PW, Yelon D: Retinoic acid signaling restricts the cardiac progenitor pool. Science 2005;307:247-249.
13. Cohen ED, Tian Y, Morrisey EE: Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 2008;135:789-798.
14. Lin X, Xu X: Distinct functions of Wnt/beta-catenin signaling in KV development and cardiac asymmetry. Development 2009;136:207-217.
15. Hu N, Sedmera D, Yost HJ, Clark EB: Structure and function of the developing zebrafish heart. Anat Rec 2000;260:148-157.
16. Fishman MC, Chien KR: Fashioning the vertebrate heart: Earliest embryonic decisions. Development 1997;124:2099-2117.
17. Teraoka H, Dong W, Hiraga T: Zebrafish as a novel experimental model for developmental toxicology. Congenit Anom 2003;43:123-132.
18. Hu N, Sedmera D, Yost HJ, Clark EB: Structure and function of the developing zebrafish heart. Anat Rec 2000;260:148-157.
19. Bakkers J: Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res 2011;91:279-288.
20. Westerfield M: The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish Danio (Brachydanio) rerio; M. Westerfield: Eugene OR USA, 1993.
21. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF: Stages of embryonic development of the zebrafish. Dev Dyn 1995;203:253-310.
22. Thisse C, Thisse B: High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 2008;3:59-69.
23. Chen JN, Fishman MC: Zebrafish tinman homolog demarcates the heart field and initiates myocardial differentiation. Development 1996;122:3809-3816.
24. Yelon D, Horne SA, Stainier DY: Restricted expression of cardiac myosin genes reveals regulated aspects of heart tube assembly in zebrafish. Dev Biol 1999;214:23-37.
25. Kloosterman WP, Steiner FA, Berezikov E, de Bruijn E, van de Belt J, Verheul M, Cuppen E, Plasterk RH: Cloning and expression of new microRNAs from zebrafish. Nucleic Acids Res 2006;34:2558-2569.
26. Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD, Chen YG: MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 2008;111:588-595.
27. Clay H, Ramakrishnan L: Multiplex fluorescent in situ hybridization in zebrafish embryos using tyramide signal amplification. Zebrafish 2007;2:105-111.
28. Rao TP, Kühl M: An Updated Overview on Wnt Signaling Pathways : A Prelude for More. Circ Res 2010;106:1798-1806.
29. MacDonald BT, Tamai K, He X: Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases. Dev Cell 2009;17:9-26.
30. Wang J, Sinha T, Wynshaw-Boris A: Wnt signaling in mammalian development: lessons from mouse genetics. Cold Spring Harb Perspect Biol 2012;4:a007963.
31. Zhang M, Zhang J, Lin SC, Meng A: beta-Catenin 1 and beta-catenin 2 play similar and distinct roles in left-right asymmetric development of zebrafish embryos. Development 2012;139:2009-2019.
32. Kim YS, Kim MJ, Koo TH, Kim JD, Koun S, Ham HJ, Lee YM, Rhee M, Yeo SY, Huh TL: Histone deacetylase is required for the activation of Wnt/beta-catenin signaling crucial for heart valve formation in zebrafish embryos. Biochem Biophys Res Commun 2012;423:140-146.
33. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM: A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-833.
34. Mendell JT: miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008;133:217-222.
35. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T: Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008;132:875-886.
36. Pullamsetti SS, Doebele C, Fischer A, Savai R, Kojonazarov B, Dahal BK, Ghofrani HA, Weissmann N, Grimminger F, Bonauer A, Seeger W, Zeiher AM, Dimmeler S, Schermuly RT: Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 2011;185:409-419.
37. van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW, Swinnen M, Cleutjens JP, van Zandvoort MA, Heymans S, Schroen B: MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell 2011;10:769-848.
38. Quaife NM, Watson O, Chico TJ: Zebrafish: an emerging model of vascular development and remodelling. Curr Opin Pharmacol 2012;12:608-614.
39. Rochais F, Mesbah K, Kelly RG: Signaling pathways controlling second heart field development. Circ Res 2009;104:933-942.
40. Puga A: Perspectives on the potential involvement of the AH receptor-dioxin axis in cardiovascular disease. Toxicol Sci 2011;120:256-261.
41. Willert K, Nusse R: Wnt proteins. Cold Spring Harb Perspect Biol 2012;4:a007864.